Morgan Stanley Reiterates Equal-Weight on Oscar Health, Maintains $5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser has reiterated an Equal-Weight rating on Oscar Health (NYSE:OSCR) and maintained a $5 price target.
July 14, 2023 | 3:08 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Oscar Health and maintained a $5 price target.
The news is directly about Oscar Health and its rating by Morgan Stanley. The Equal-Weight rating suggests that the stock is expected to perform in line with the market or other stocks in its sector. The maintained price target of $5 indicates that the analyst does not foresee significant price movement in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100